|
Ganz, P.A., Romond, E.H., Cecchini, R.S., Rastogi, P., Geyer, C.E., Jr, Swain, S.M., Jeong, J.H., Fehrenbacher, L., Gross, H.M., Brufsky, A.M., Flynn, P.J., Wahl, T.A., Seay, T.E., Wade, J.L.III, Biggs, D.D, Atkins, J.N., Polikoff, J., Zapas, J.L., Mamounas, E.P., Wolmark, N. Long term follow up of cardiac function and quality of life for patients in NSABP Protocol B-31/NRG Oncology: a randomized trial comparing the safety and efficacy of Doxorubicin and Cyclophosphamide (AS) followed by Paclitaxel with AC followed by Paclitaxel and Trastuzumab in patients with node positive breast cancer with tumors over expressing Human Epidermal Growth factor receptor. Journal of Clinical Oncology. 2017.
|